Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis

Free Subscription Articles published in Vaccine Retrieve available abstracts of 97 articles: HTML format Text format

Single Articles

January 2012
1. WANG F , Zhao YL, Ma JC, Bi SL, et al
   Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. WANG YS , Ouyang W, Liu XJ, He KW, et al
   Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. FABRIZI F , Dixit V, Messa P, Martin P, et al
   Hepatitis B virus vaccine in chronic kidney disease: Improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. OTT JJ , Stevens GA, Groeger J, Wiersma ST, et al
   Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BECK CR , Cloke R, O'Moore E, Puleston R, et al
   Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: A retrospective ecological study.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHAVES SS , Fischer G, Groeger J, Patel PR, et al
   Persistence of long-term immunity to hepatitis B among adolescents immunized at birth.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MINERVINI G , McCarson BJ, Reisinger KS, Martin JC, et al
   Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
   Vaccine. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
8. HAHNE S , van den Hoek A, Baayen D, van der Sande M, et al
   Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: Children of Chinese mothers are at increased risk of breakthrough infection.
   Vaccine. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. VAN RIJSWOUD E
   Reply to "Preparing for the next public debate: Universal vaccination against hepatitis B"Vaccine 29 (8 November 2011), pp. 8960-8964.
   Vaccine. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. ZITT E , Sprenger-Mahr H, Knoll F, Neyer U, et al
    Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. SHARMA HJ , Patil VD, Lalwani SK, Mangalani MV, et al
    Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. TRAN TQ , Grimes CZ, Lai D, Troisi CL, et al
    Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ZHAO Z , Murphy TV, Jacques-Carroll L
    Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
14. CHAVES SS , Daniels D, Cooper BW, Malo-Schlegel S, et al
    Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. KACHKO A , Kochneva G, Sivolobova G, Grazhdantseva A, et al
    New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. HARDER KM , Cowan S, Eriksen MB, Krarup HB, et al
    Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. TOHME RA , Awosika-Olumo D, Nielsen C, Khuwaja S, et al
    Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. FREED DC , Towne VM, Casimiro DR, Zhao Q, et al
    Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ABARCA K , Ibanez I, de la Fuente P, Cerda L, et al
    Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
20. FITZSIMONS D , Kojouharova M, Hallauer J, Hendrickx G, et al
    Burden and prevention of viral hepatitis in Bulgaria.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HOUWELING H , Spaendonck MC, Paulussen T, Verweij M, et al
    Preparing for the next public debate: Universal vaccination against hepatitis B.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. WINNOCK M , Bani-Sadr F, Pambrun E, Loko MA, et al
    Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ALAVI-MOGHADDAM M , Alavian SM, Aalaei-Andabili SH, Eslami-Far A, et al
    Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-alpha among naive chronic hepatitis B patients?
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
24. ZHENG H , Chen Y, Wang F, Gong X, et al
    Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. LEE AW , Vesikari T, Gilbert CL, Klopfer SO, et al
    Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SCHMEINK CE
    Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. ZHU CL , Liu P, Chen T, Ni Z, et al
    Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
28. LU PJ , Byrd KK, Murphy TV, Weinbaum C, et al
    Hepatitis B vaccination coverage among high-risk adults 18-49 years, U.S., 2009.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KURUGOL Z , Aslan A, Turkoglu E, Koturoglu G, et al
    Changing epidemiology of hepatitis A infection in Izmir, Turkey.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. RAY P , Black S, Shinefield H, Dillon A, et al
    Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
31. ISAACS D , Kilham HA, Alexander S, Wood N, et al
    Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. PASSOS AM , Treitinger A, Spada C
    Hepatitis B immunity and vaccination coverage among young adult males in the Air Force in South Brazil.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ZHANG W , Han L, Lin C, Wang H, et al
    Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. GIMENEZ-SANCHEZ F , Kieninger DM, Kueper K, Martinon-Torres F, et al
    Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal con
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. YIN Y , Li H, Wu S, Dong D, et al
    Hepatitis B virus core particles displaying Mycobacterium tuberculosis antigen ESAT-6 enhance ESAT-6-specific immune responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. VON TEICHMAN B
    Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
37. PAULKE-KORINEK M , Fischmeister G, Grac A, Rendi-Wagner P, et al
    Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MELO LV , Silva MA, Calcada CD, Cavalcante SR, et al
    Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: Assessment of prevalence and vaccination coverage.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HONG Y , Peng Y, Mi M, Xiao H, et al
    Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.
    Vaccine. 2011;29:3909-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. CORTE CD , Carlucci A, Francalanci P, Alisi A, et al
    Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SAKSAWAD R , Likitnukul S, Warachit B, Hanvivatvong O, et al
    Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. HATZ C , Beck B, Steffen R, Genton B, et al
    Real-life versus package insert: A post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal((R)) in healthy travellers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. AKAZAWA D , Morikawa K, Omi N, Takahashi H, et al
    Production and characterization of HCV particles from serum-free culture.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BOSHRA H , Lorenzo G, Rodriguez F, Brun A, et al
    A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
45. LAO-ARAYA M , Puthanakit T, Aurpibul L, Taecharoenkul S, et al
    Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
46. LIN SY , Liu JH, Lin CC, Wang SM, et al
    Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZHANG Y , Ma JC, Qi SX, Wang F, et al
    Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. STRATEN PT , Andersen MH
    Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
49. BURNETT RJ , Francois G, Mphahlele MJ, Mureithi JG, et al
    Hepatitis B vaccination coverage in healthcare workers in Gauteng Province, South Africa.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. WANG H , Su X, Zhang P, Liang J, et al
    Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-specific CTL responses.
    Vaccine. 2011;29:2328-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. CAO J , Chen Z, Ren Y, Luo Y, et al
    Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. CEKMEZ F , Canpolat FE, Erdinc K, Cetinkaya M, et al
    Response to hepatitis B vaccine differs by birthweight among neonates.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MOORMAN JP , Zhang CL, Ni L, Ma CJ, et al
    Impaired hepatitis B vaccine responses during chronic hepatitis C infection: Involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
54. RUSNAK JM , Gibbs P, Boudreau E, Clizbe DP, et al
    Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BYRD KK , Santibanez TA, Chaves SS
    Predictors of hepatitis A vaccination among young children in the United States.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. NAARDING MA , Falkowska E, Xiao H, Dragic T, et al
    Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. CHAKVETADZE C , Roussin C, Roux J, Mallet V, et al
    Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. BUNUPURADAH T , Ananworanich J, Pancharoen C, Petoumenos K, et al
    Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TSOU TP , Liu CC, Huang JJ, Tsai KJ, et al
    Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. MOGHADDAM MH , Shadkam MN, Hadinedoushan H
    Immunity to hepatitis B vaccine among health care workers.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ELEFTHERIADIS T , Liakopoulos V, Antoniadi G, Stefanidis I, et al
    Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
62. WU Q , Zhuang GH, Wang XL, Wang LR, et al
    Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: Results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
63. TIELEMANS CL , Vlasak J, Kosa D, Billiouw JM, et al
    Immunogenicity and safety of an investigational as02(v)-adjuvanted hepatitis b vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative tria
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. SHIM J , Kim KY, Kim BH, Chun H, et al
    Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. DIAZ-MITOMA F , Halperin SA, Tapiero B, Hoffenbach A, et al
    Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
66. ZINGONE F , Morisco F, Zanetti A, Romano L, et al
    Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. SOBEL HL , Mantaring JB 3rd, Cuevas F, Ducusin JV, et al
    Implementing a national policy for hepatitis B birth dose vaccination in Philippines: Lessons for improved delivery.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. CHEN J , Liang Z, Lu F, Fang X, et al
    Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. SIDDIQUI MR , Gay N, Edmunds WJ, Ramsay M, et al
    Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
70. MATHESON K , Halperin B, McNeil S, Langley JM, et al
    Hepatitis A and travel amongst Nova Scotia post-secondary students: Evidence for a targeted vs. universal immunization strategy.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. WANG XY , Zhang XX, Yao X, Jiang JH, et al
    Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. STAAT MA , Stadler LP, Donauer S, Trehan I, et al
    Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. HOUWELING H , Wittevrongel CF, Verweij M, Ruitenberg EJ, et al
    Public vaccination programmes against hepatitis B in The Netherlands: Assessing whether a targeted or a universal approach is appropriate.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
74. FISCHINGER JM , Stephan B, Wasserscheid K, Eichler H, et al
    A cost-benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. BOGGILD AK , Castelli F, Gautret P, Torresi J, et al
    Vaccine preventable diseases in returned international travelers: Results from the GeoSentinel Surveillance Network.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. GUAN ZJ , Guo B, Huo YL, Guan ZP, et al
    Overview of expression of hepatitis B surface antigen in transgenic plants.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. FENG F , Teoh CQ, Qiao Q, Boyle D, et al
    The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. MACDONALD LD , Fuentes-Ortega A, Sammatur L, Mansour M, et al
    Efficacy of a single dose hepatitis B depot vaccine.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. SHEN M , Wang S, Ge G, Xing Y, et al
    Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. MAHER L , White B, Hellard M, Madden A, et al
    Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
81. MONGILLO M , Chiara F, Ranzato M, Trevisan A, et al
    Strategy for hepatitis A seroprevalence survey in a population of young people.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. JACOBSEN KH , Wiersma ST
    Hepatitis A virus seroprevalence by age and world region, 1990 and 2005.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. AMEISS K , Ashraf S, Kong W, Pekosz A, et al
    Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. MARTINELLI D , Bitetto I, Tafuri S, Lopalco PL, et al
    Control of hepatitis A by universal vaccination of children and adolescents: An achieved goal or a deferred appointment?
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
85. VALATS JC , Tuaillon E, Funakoshi N, Hoa D, et al
    Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. KRAMVIS A , Clements CJ
    Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa-Too soon?
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. OCHOA-CALLEJERO L , Otano I, Vales A, Olague C, et al
    Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice.
    Vaccine. 2010;28:5323-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. LEVY V , Evans JL, Stein ES, Davidson PJ, et al
    Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. CUI F , Li L, Hadler SC, Wang F, et al
    Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. SINGLETON RJ , Hess S, Bulkow LR, Castrodale L, et al
    Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. BERAN J , Kervyn D, Wertzova V, Hobzova L, et al
    Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. XU L , Wei Y, Chen T, Lu J, et al
    Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
93. OCHOA-CALLEJERO L , Otano I, Vales A, Olague C, et al
    Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. DUNGU B , Louw I, Lubisi A, Hunter P, et al
    Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
95. KORTEKAAS J , de Boer SM, Kant J, Vloet RP, et al
    Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. QING Y , Zhao J, Chen M, Xu H, et al
    Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice.
    Vaccine. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. CHO HY , Kim CH, Go UY, Lee HJ, et al
    Immunization decision-making in the Republic of Korea: the structure and functioning of the Korea Advisory Committee on Immunization Practices.
    Vaccine. 2010;28 Suppl 1:A91-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: